Cue Biopharma Inc (NAS:CUE)
$ 26.87 -0.10 (-0.37%) Market Cap: 112.86 Mil Enterprise Value: 99.92 Mil PE Ratio: 0 PB Ratio: 4.05 GF Score: 45/100

Cue Biopharma Inc Extraordinary Shareholders Meeting Transcript

Jun 01, 2026 / 01:00PM GMT
Release Date Price: $24.07 (+9.89%)
Shao;Lee Lin Cue Biopharma Inc;President
Chief Executive Officer, Director

Good morning, and welcome to our special meeting of the stockholders of Cue Biopharma Inc. I am Shao-Lee Lin, the company's President and Chief Executive Officer, and I now call this meeting to order.

As you know, we are hosting today's meeting through a virtual online platform hosted by Broadridge. I will act as the presiding officer of this meeting, and Tony Carideo of the Carideo Group will act as Inspector of Election. Mr. Carideo has taken and subscribed the customer oath of office to execute his duties with strict impartiality. We will file this oath with the records of the meeting. Colin Sandercock, the company's Senior Vice President, General Counsel, and Secretary, will act as secretary of the meeting.

I will now turn to the formal part of the meeting. Please note that various remarks that we may make about future expectations, plans and prospects for the company constitute forward-looking statements for purposes of the Safe Harbor provisions under the Private

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot